Maximizing the return on taxpayers' investments in fundamental biomedical research
Authors:
- Jon R. LorschJLJon R. Lorsch
- Mark PeiferMPMark Peifer
- Monitoring Editor Doug KelloggMKMonitoring Editor Doug Kellogg
- George M. SantangeloGSGeorge M. Santangelo
- Stefano BertuzziSBStefano Bertuzzi
- Elizabeth MarincolaEMElizabeth Marincola
- Frank SolomonFSFrank Solomon
- Michael P. SheetzMSMichael P. Sheetz
- C BenderCBC Bender
- S WardSWS Ward
- M A WellsMWM A Wells
Open Access
- 1 May 2015
- journal article
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 26 (9) , 1578-1582
Abstract
The National Institute of General Medical Sciences (NIGMS) at the U.S. National Institutes of Health has an annual budget of more than $2.3 billion. The institute uses these funds to support fundamental biomedical research and training at universities, medical schools, and other institutions across the country. My job as director of NIGMS is to work to maximize the scientific returns on the taxpayers' investments. I describe how we are optimizing our investment strategies and funding mechanisms, and how, in the process, we hope to create a more efficient and sustainable biomedical research enterprise.Keywords
This publication has 16 references indexed in Scilit:
- Citation Impact of NHLBI R01 Grants Funded Through the American Recovery and Reinvestment Act as Compared to R01 Grants Funded Through a Standard PaylineCirculation Research, 2015
- A generation at risk: Young investigators and the future of the biomedical workforceProceedings of the National Academy of Sciences, 2015
- The Validation of Peer Review through Research Impact Measures and the Implications for Funding StrategiesPLOS ONE, 2014
- Rescuing US biomedical research from its systemic flawsProceedings of the National Academy of Sciences, 2014
- Scientific approaches to science policyMolecular Biology of the Cell, 2013
- A fair deal for PhD students and postdocseLife, 2013
- A recipe for mediocrity and disaster, in five axiomseLife, 2013
- Big Science vs. Little Science: How Scientific Impact Scales with FundingPLOS ONE, 2013
- The writing on the walleLife, 2013
- Limits to growth: in biology, small science is good scienceCell, 1985